WCG acquires endpoint adjudication and data monitoring firm

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/shironosov)
(Image: Getty/shironosov)
WCG is expanding its Clinical Services Division to include endpoint adjudication and data monitoring services with the acquisition of ACI Clinical.

ACI Clinical’s global network includes more than 500 medical, statistical, and safety experts.

Following the acquisition – terms of which were not disclosed – ACI Clinical will continue to operate as an independent service organization within WCG’s Clinical Services Division.

“Together with WCG, we will work with clinical trial sponsors, academic experts and regulatory agencies to enhance trial integrity, reduce variation in important clinical trial events and ultimately mitigate risk and enhance patient safety in clinical trials,”​ said Jonathan Seltzer, MD, MBA, MA, FACC, president and CEO of ACI Clinical.

WCG has made several acquisitions over the last year​, in areas such as patient recruitment​, electronic consent​ (eConsent), and pharmacovigilance​. 

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Next generation ePRO from SQN Health

Next generation ePRO from SQN Health

Syne Qua Non Clinical | 16-May-2018 | Business Advice

In an era of rapid technology growth, healthcare requires low cost solutions for real-time data collection. We have come a long way from paper to EDC and...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars